U.S. federal agency safeguarding food, drug, and medical product safety
President Trump has signed an executive order directing federal health officials to cut the federal recommended childhood vaccine list, to split the combined MMR vaccine into separate measles, mumps and rubella doses once single‑disease products are available, and to space routine immunisations across separate medical visits. Public health groups and drugmakers have said the changes lack scientific support and will increase missed vaccinations during a major U.S. measles outbreak.
Nvidia has announced memorandums with six Wall Street firms to assemble about $500 billion to finance AI infrastructure — data centres, GPU clusters and related compute — for customers that lack cash or credit. Executives are pitching compute as an investable asset class while analysts warn depreciation risk and competition from China could erode collateral value.
A body of research shows workers are retroactively editing LinkedIn profiles to include AI skills, while hiring processes face longer cycles and rising candidate skepticism. The trend pushes AI fluency to the fore as employers seek to separate genuine experience from AI-assisted claims.
The Democratic Republic of Congo has recorded an unprecedented Bundibugyo Ebola outbreak that has spread across six provinces and produced more than 5,000 confirmed cases and over 2,600 deaths. WHO and partners have allocated 70,000 Ervebo vaccine doses—20,000 for a Phase III trial and 50,000 for frontline workers—while CEPI has funded a Bundibugyo-specific vaccine and the US has sent MBP134 treatment vials to Uganda.
UK health agencies say salmonella infections may be linked to eggs imported from outside the UK. One fatality has been confirmed. Public health guidance urges vulnerable groups to avoid under‑cooked eggs, while well‑cooked eggs remain safe. The outbreak has affected England most, with hundreds of cases across the UK.
The Kennedy Center’s board has voted to inscribe President Donald J. Trump’s name on the building’s facade, or create a Trump-backed inscription, while a federal judge’s May ruling has kept Trump’s name off. Ohio Democrat Beatty is seeking a temporary block as legal arguments unfold; implications hinge on Congress’s actions and the center’s finances.
A MAHA-backed letter to Trump, Kennedy and cabinet officials has voiced health-first concerns about coal-powered data centers and urged a shift toward solar, geothermal, and efficiency. The move signals growing friction between MAHA activists and the administration as data centers draw increasing scrutiny.
A multi-state outbreak tied to alfalfa sprouts has infected at least 55 people nationwide, including four hospitalizations. Cases are linked to Minnesota grower Everything Sprouts and its Calco and Everything Sprouts brands. FDA and CDC are coordinating testing and monitoring, with recalls and safety reviews ongoing.
A review of mobility and balance assessments shows they indicate functional health and fall risk, not life expectancy. Tests like sit-to-stand and Timed Up and Go help identify weaknesses and guide care, while researchers note variability across populations.
New observational data suggests Shingrix vaccination in older adults is associated with lower cardiovascular risk and reduced dementia incidence over multi-year follow-ups. Studies compare Shingrix to Zostavax and find reductions in heart disease, stroke, and dementia, with stronger signals in men for heart outcomes.
The FDA has approved daraxonrasib, sold as Rasonque by Revolution Medicines, for adults with previously treated or ineligible metastatic pancreatic cancer. Clinical trials have shown median survival extended to about 13.2 months versus roughly 6.7 months with chemotherapy. The drug will be available in the US with a roughly $39,800 monthly list price and expanded-access programmes have already treated thousands.
General Mills has shifted to natural colorings derived from fruits, vegetables and spices in most U.S. cereals. About 90% of U.S. retail products are now free of artificial dyes, with remaining items set to convert by end-2027. Kellogg has followed suit, and other major brands have pledged to remove synthetic dyes amid regulatory and consumer pressure.
Multiple recalls are rippling through the US food system. A donut recall in March labeling issues, several wraps tied to STEC, and a broad recall wave linked to peppers and berries highlight ongoing safety concerns. Authorities urge discard or return of affected items and emphasize consumer safety as top priority.
The FDA has identified new Cyclospora cases in Georgia, Tennessee and Texas, bringing total illness to 11,458. Investigations center on lettuce from a Taylor Farms farm in central Mexico. Officials say recalls are complete and monitoring continues, with hospitalizations near 922 this year.
Major US medical societies have issued unified guidance this week for flu, COVID-19 and RSV vaccines after the CDC’s advisory process has been disrupted. Updated COVID shots have FDA approval and manufacturers are shipping doses, but legal and policy disputes over federal recommendations continue to leave states and insurers uncertain about timing and coverage.
The Corte Madera Town Council votes to advance an ordinance banning tobacco and nicotine products, including vapes, with a transition through Jan. 31, 2027. Residents may keep possessions. Public comment highlighted concerns from students and families affected by tobacco-related illness.
GLP-1 medications are being increasingly prescribed off-label to children aged 8–11 in the US, despite no FDA approval for under-12s. A NYU Langone study shows a dramatic rise in June 2026, while experts warn about long-term effects and the broader obesity crisis.
Investors have pushed new biotech winners — from Novo Nordisk’s semaglutide pill to startups tackling baldness and targeted autoimmune drugs — while market enthusiasm has cooled for some forecasts. Novo Nordisk has released a daily weight‑loss pill used by over 1.5 million people; hair‑loss startups have sent small caps soaring; India’s low‑cost GLP‑1 generics have underperformed expectations.
Several women in Africa and the UK face long waits for fibroid treatment and endometriosis diagnosis, highlighting delays in access to care, testing, and surgical options. New tests abroad offer hope, but are not yet widely available in the US.
The US Centers for Disease Control and Prevention has declared the multistate cyclospora outbreak tied to iceberg lettuce over after cases have fallen sharply. Federal investigators have linked the outbreak to iceberg lettuce imported from central Mexico by Taylor Farms; about 12,800 people were infected, 570 were hospitalised and two people died.
A synthesis of recent sleep studies shows wearables may misjudge sleep quality, narcolepsy treatment advances gain regulatory traction, and weekend catch-up sleep ties to lower hypertension risk, prompting a nuanced view of how to monitor and improve sleep.
Flu vaccines are underway and updated COVID-19 shots are arriving nationwide after FDA approval. RSV remains a threat, prompting guidance from medical societies as Trump health officials rethink autumn vaccine policies. An advisory panel remains in a legal dispute, while doctors push clear, science-based guidance. Older adults and high-risk groups are urged to vaccinate, with a new mRNA flu shot showing improved effectiveness.
McKenna West has filed an emergency appeal seeking to halt a California court order that recognizes California couple Omar Ahmed and Nausheen Gilkar as the parents of a seriously ill infant. The child, born with hypoplastic left heart syndrome, has undergone surgery. West argues the couple would withhold life-saving care; the Supreme Court’s involvement remains uncertain.
The FDA has cleared four blood tests to help diagnose Alzheimer's in people with memory problems, a move that could speed access to therapies. Experts caution that tests are not for asymptomatic individuals, and many questions remain about accuracy. Readers are advised to focus on brain-healthy risks like blood pressure, diabetes and smoking.
The administration has proposed aligning U.S. Medicare drug prices with those in other wealthy countries to curb costs. Bloomberg reports show that under this MFN-style approach, many products could see price reductions, though research indicates some drugs would reduce overall US revenue. The update highlights ongoing tensions over affordability, access, and industry resistance.
The Justice Department has reached a settlement with Abbott over the Sturgis, Michigan plant that produced a major share of U.S. infant formula. The settlement addresses unsanitary conditions and recalls tied to Cronobacter sakazakii, while Abbott maintains no admission of fault. Regulators say the plant’s issues contributed to a nationwide shortage.
Saphier has been nominated to serve as surgeon general. She is navigating questions about vaccine policy, credentials, and potential conflicts of interest as lawmakers scrutinize her readiness to lead public health messaging.
A three‑judge panel of the 1st US Circuit Court of Appeals has largely upheld a lower court ruling that found the Department of Homeland Security’s third‑country removal policy unlawful, saying migrants must get a meaningful chance to raise safety concerns before removal. The panel narrowed one part of the decision on procedural grounds. The administration is expected to appeal.
Novo has laid out a plan to diversify beyond Wegovy and Ozempic as it faces looming exclusivity losses. Capital Markets Day signals a push into cardiovascular, liver and blood disorders with a target to expand its pipeline, while investors question credibility and near-term milestones amid a evolving GLP-1 landscape dominated by Lilly.
Influencer Braden Peters, known online as Clavicular, has been charged in Massachusetts with rape, providing liquor to a minor, and drugging for sexual intercourse, linked to an alleged May 2025 incident on Cape Cod. A separate Florida civil suit accuses him of coercion and non-consensual procedures. Peters denies the accusations and faces further legal proceedings.
Two Ole Miss students have died in separate locations. Authorities say kratom was found at the scenes, but there is no confirmed information that kratom contributed to either death. Investigations are ongoing; toxicology reports are being expedited.
Lawsuits allege GLP-1 diabetes drugs may cause nonarteritic anterior ischemic optic neuropathy (NAION), an eye condition that can cause permanent vision loss. Novo Nordisk and Eli Lilly dispute the claims as regulators review data; meanwhile trials and studies show mixed signals about risk.
The Speaker is campaigning across multiple states to defend Republican-held seats while pursuing a broader message on cost of living and reform. The push follows a six-week sprint across 20 states, with a focus on key battlegrounds as November nears.
A recall first issued in July has expanded to include more frozen berry products tied to an E. coli outbreak that has infected at least 17 people across Florida and Georgia. The FDA warns consumers to discard affected products and seek refunds. Public health officials say the outbreak, now linked to Frutas y Hortalizas del Sur S.A., has prompted recalls across retailers including Walmart and Trader Joe’s.
The FDA has closed its investigation into the Taylor Farms cyclospora outbreak linked to lettuce. Investigators found cyclospora in a wastewater tank and a drainage ditch at the Taylor Farms site in Guanajuato, Mexico, but the agency says it is unclear how contamination occurred. The outbreak had caused nearly 13,000 illnesses across the United States.
The Supreme Court is evaluating whether federal law preempts state and local lawsuits accusing oil companies of climate-related damages. Boulder, Colorado, leads a wave of cases seeking damages for disaster costs, with ExxonMobil and Suncor among the defendants. The decision could affect dozens of similar lawsuits nationwide.
PepsiCo has initiated a class II recall after undeclared Yellow No. 5 and/or No. 6 dyes were found in several Gatorade flavors. The recall covers 28-ounce bottles distributed across 37 states. Consumers are advised not to drink affected products and to seek refunds; the FDA classifies the risk as mid-level.
A federal lawsuit in Seattle accuses Starbucks of labeling eight protein drinks as sugar-free while containing 13–21 grams of sugar per venti, prompting questions about added vs. total sugar and FDA labeling rules. Starbucks denies wrongdoing and says the sugar comes from lactose in milk.
The Justice Department has reached a settlement with CVS over a 2024 lawsuit that accused the company of dispensing large quantities of opioids and other controlled substances to fuel profits, sidelining public health. The agreement requires additional safeguards to ensure prescriptions are medically appropriate, with no admission of wrongdoing by CVS.
The administration has moved to allow some popular, yet unproven, injectable peptides to be temporarily manufactured by specialty pharmacies. The plan, still subject to White House review, would use enforcement discretion to avoid immediate enforcement of current restrictions, while a formal rulemaking process could take years.